MARKET

AUVI

AUVI

Applied UV, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.14
+0.04
+0.78%
After Hours: 5.08 -0.06 -1.17% 19:42 11/29 EST
OPEN
5.08
PREV CLOSE
5.10
HIGH
5.44
LOW
4.820
VOLUME
319.58K
TURNOVER
--
52 WEEK HIGH
35.78
52 WEEK LOW
4.290
MARKET CAP
32.86M
P/E (TTM)
-4.8145
1D
5D
1M
3M
1Y
5Y
RLX Technology among consumer gainers; Nordstrom and The Gap lead losers
Gainers: Grom Social Enterprises (NASDAQ:GROM) +17%. Spark Networks (NYSE:LOV) +19%. Applied UV (NASDAQ:AUVI) +17%. Engine Gaming and Media (NASDAQ:GAME) +16%. RLX Technology (NYSE:RLX) +14%. Losers: Nordstrom (NYSE:JWN) -29%. The Gap (NYSE:GPS) -22%.
Seekingalpha · 5d ago
Applied UV Declares Monthly Preferred Stock Dividend
MOUNT VERNON, NY / ACCESSWIRE / November 23, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and...
AccessWire · 6d ago
Applied UV's Return On Capital Employed Insights
According to Benzinga Pro data, during Q3, Applied UV (NASDAQ:AUVI) posted sales of $3.55 million. Earnings were up 24.98%, but Applied UV still reported an overall loss of $1.63 million.
Benzinga · 11/16 17:46
Applied UV EPS misses by $0.01, beats on revenue
Applied UV (NASDAQ:AUVI): Q3 GAAP EPS of -$0.14 misses by $0.01. Revenue of $3.55M (+127.6% Y/Y) beats by $0.65M. Press Release
Seekingalpha · 11/16 12:17
Applied UV Q3 EPS $(0.14) Misses $(0.13) Estimate, Sales $3.55M Beat $2.90M Estimate
Applied UV (NASDAQ:AUVI) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.13) by 7.69 percent. This is unchanged from the same period last year. The company reported
Benzinga · 11/16 12:10
Applied UV Reports Third Quarter 2021 Results
Results: * Revenue increased 88.88 in the previous quarter * Gross profit increased to $1.
ACCESSWIRE · 11/16 12:00
Earnings Scheduled For November 16, 2021
  Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million.
Benzinga · 11/16 09:06
Diamond Equity Research Emerging Growth Invitational Winter 2021 Spotlight Virtual Conference
30 Minute presenting time slots from 9am to 1pm EST November 16, 2021Presentation times and links distributed for all presenting companiesInvestors will be provided time after presentation to ask questionsWelcome all institutional and retail investors NEW ...
GlobeNewswire · 11/15 14:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AUVI. Analyze the recent business situations of Applied UV, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

100.00%Strong Buy
0.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average AUVI stock price target is 17.75 with a high estimate of 17.75 and a low estimate of 17.75.
High17.75
Average17.75
Low17.75
Current 5.14
EPS
Actual
Estimate
-0.27-0.18-0.09-0.00
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 15
Institutional Holdings: 276.23K
% Owned: 4.32%
Shares Outstanding: 6.39M
TypeInstitutionsShares
Increased
5
35.89K
New
4
30.15K
Decreased
4
6.17K
Sold Out
5
52.69K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About AUVI
Applied UV, Inc. is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company's disinfectant segment is engaged in the design, manufacture, assembly and distribution of disinfecting systems for use in healthcare, hospitality, and commercial municipal and residential markets. Its hospitality segment is engaged in the manufacture of mirrors specifically for the hospitality industry. Its subsidiary, SteriLumen, Inc. (SteriLumen), develops and acquires medical devices that eliminate pathogens that may cause healthcare-acquiured infections (HAIs) for distribution primarily to facilities that have customer turnover, such as hospitals, assisted living facilities, doctors’ offices and walk-in clinics as well as other public spaces. It manufactures and supplies decorative framed mirrors, framed art, and vanities primarily to the hospitality market through Munn Works, LLC (Munn Works).

Webull offers kinds of Applied UV Inc stock information, including NASDAQ:AUVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AUVI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AUVI stock methods without spending real money on the virtual paper trading platform.